Journal of Lipid Research, Vol 33, 1629-1637, Copyright © 1992 by Lipid Research, Inc.
Sulfonate analogues of chenodeoxycholic acid: metabolism of sodium 3 alpha, 7 alpha-dihydroxy-25-homo-5 beta-cholane-25-sulfonate and sodium 3 alpha, 7 alpha-dihydroxy-24-nor-5 beta-cholane-23-sulfonate in the hamster
S Miki, EH Mosbach, BI Cohen, M Yoshii, N Ayyad and CK McSherry
Department of Surgery, Beth Israel Medical Center, New York, NY 10003.
This report describes the chemical synthesis of a new bile acid analogue,
namely, sodium 3 alpha, 7 alpha-dihydroxy-25-homo-5 beta-
cholane-25-sulfonate from homochenodeoxycholic acid. The structure of the
new compound was assigned by proton magnetic resonance and infrared
spectrometry. Its metabolism was studied in the hamster in comparison with
sodium 3 alpha, 7 alpha-dihydroxy-24-nor-5 beta-cholane-23- sulfonate and
sodium taurochenodeoxycholate. After intraduodenal administration of the
3H-labeled analogues into bile fistula hamsters, both sulfonates were
absorbed from the intestine and nearly 80% of the radioactivity was
secreted into bile within 8 h. Intra-ileal administration revealed that
these compounds resembled taurochenodeoxycholate in that they were much
more rapidly absorbed from the ileum than from the proximal small
intestine: more than 85% of the radioactivity was recovered in bile within
1 h. After intravenous infusion the sulfonates were efficiently extracted
by the liver at rates similar to that of sodium taurochenodeoxycholate.
Chromatographic analysis of the bile showed that, regardless of the route
of administration, most (> 95%) of the sulfonates were not
biotransformed and they became major biliary bile acids. Sodium 3 alpha, 7
alpha- dihydroxy-25-homo-5 beta-cholane-25-sulfonate and, to a lesser
extent, sodium 3 alpha, 7 alpha-dihydroxy-24-nor-5
beta-cholane-23-sulfonate induced cholestasis at infusion rates at which
sodium taurochenodeoxycholate produced choleresis.